Sino Biopharmaceutical Limited
SBMFF
$0.9891
$0.03914.12%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | 208.32M | 210.13M | -- |
| Total Depreciation and Amortization | -- | -- | 35.23M | 35.53M | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -31.00M | -31.26M | -- |
| Change in Net Operating Assets | -- | -- | -- | -- | -- |
| Cash from Operations | -- | -- | 212.56M | 214.40M | -- |
| Capital Expenditure | -- | -- | -28.14M | -28.38M | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | 97.33M | 98.18M | -- |
| Other Investing Activities | -- | -- | -210.11M | -211.93M | -- |
| Cash from Investing | -- | -- | -140.92M | -142.14M | -- |
| Total Debt Issued | -- | -- | 3.36B | 3.36B | -- |
| Total Debt Repaid | -- | -- | -4.70B | -4.70B | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -180.78M | -180.78M | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -527.10M | -527.10M | -- |
| Cash from Financing | -- | -- | -283.05M | -285.50M | -- |
| Foreign Exchange rate Adjustments | -- | -- | 1.81M | 1.83M | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | -209.60M | -211.41M | -- |